CLINICAL FEATURES OF COGNITIVE DISORDERS IN HYPERTONIC DISEASE
Keywords:
hypertension, cognitive disorders, dementia, mnestic disordersAbstract
The article is devoted to one of the most pressing problems of clinical medicine - impairment of cognitive functions in hypertension. The paper presents modern data on the prevalence of cognitive impairments developing against the background of hypertension, and discusses in detail their pathogenesis and clinical features. The basic methods of neuropsychological research used in the diagnosis of cognitive impairment in hypertension are presented. The results of international clinical trials on nonspecific and specific therapy of cognitive impairment in hypertension are considered in detail.
References
Dufouil C, Chalmers J. Coskun O. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy // Circulation-2005.-112 (11) P.1644-1650. 1. Cerebrovascular disease, cognitive impairment and dementia. Second edition of Cerebrovascular disease and dementia. Edited by O'Brien J, Ames D., Gustafson L. Et al-Martin Dunitz-2014.
Hershey LA, Olszewski WA // Handbook of Dementing Illnesses / Ed. by JC Morris NY, 2016. P.335-351.
Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party // Br. Med. J. 2018. V. 304. No. 6824. P. 405.
Pantoni L. et al. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study // Journal of the American Geriatrics Society.-2006. T. 54. No. 7.-S. 1095-1101.
Ruitenberg A, et al. // Dement. Geriatr. Cogn. Disord. 2012. V. 12. No. L. P. 33.
Skoog 1. Gustafson D. // Dementia Therapeutic Research / Ed. by K. Rockwood, S. Gauthier. London; NY, 2016. P. 189-212.
Schrader J, Luders S. Kulschewski A et al. Mortality and morbidity after stroke, Eprosartan compared with Nitrendipine for secondary prevention. Principal results of a prospective randomized controlled study (MOSES). // Stroke 2005; 36: 1218-1226.
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic Hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) SHEP Cooperativ I 26 No. 24, P 325 Screenshot has been saved to
